REGENERATIVE · THERAPY
REGENERATIVE · THERAPY
Wharton's Jelly Therapy
Wharton's Jelly Therapy
Wharton's Jelly Therapy
Wharton's jelly therapy is one of the regenerative options patients ask about at TC Regen Naples and TC Regen Fort Myers, using a tissue product derived from donated umbilical cord that is studied for its role in supporting the body's repair response.
Wharton's jelly therapy is one of the regenerative options patients ask about at TC Regen Naples and TC Regen Fort Myers, using a tissue product derived from donated umbilical cord that is studied for its role in supporting the body's repair response.
Wharton's jelly therapy is one of the regenerative options patients ask about at TC Regen Naples and TC Regen Fort Myers, using a tissue product derived from donated umbilical cord that is studied for its role in supporting the body's repair response.
The challenge
The challenge
Patients researching regenerative options often encounter "Wharton's jelly" alongside stem cells and exosomes and aren't sure what it is or how it differs. Many want a clear, honest explanation of where the tissue comes from, what is and isn't established about it, and whether it is an appropriate option for an orthopedic or pain condition.
Patients researching regenerative options often encounter "Wharton's jelly" alongside stem cells and exosomes and aren't sure what it is or how it differs. Many want a clear, honest explanation of where the tissue comes from, what is and isn't established about it, and whether it is an appropriate option for an orthopedic or pain condition.
Patients researching regenerative options often encounter "Wharton's jelly" alongside stem cells and exosomes and aren't sure what it is or how it differs. Many want a clear, honest explanation of where the tissue comes from, what is and isn't established about it, and whether it is an appropriate option for an orthopedic or pain condition.
Wharton's Jelly Therapy
Wharton's Jelly Therapy
The Process
The Process
Wharton's jelly therapy at TC Regen begins with a physician evaluation to confirm the diagnosis and determine whether it is an appropriate option. Wharton's jelly is a connective tissue from donated umbilical cord, screened and processed by the supplier before use. It is studied for its potential role in supporting tissue repair, and is not approved by the U.S. Food and Drug Administration. TC Regen provides it only with written informed consent.
What Wharton's Jelly Is
Wharton's jelly is the gelatinous connective tissue found within the umbilical cord, donated after full-term, healthy births and screened according to applicable tissue-sourcing standards. In regenerative medicine it is studied for its potential to support the body's natural repair processes. Research into Wharton's jelly for orthopedic and musculoskeletal use is still developing, and TC Regen discusses what is and is not established with each patient.
How TC Regen Uses It
At TC Regen, Wharton's jelly therapy is delivered by injection under image guidance to the targeted area, selected by the physician based on the structural diagnosis. Because these tissue products are not FDA-approved, the treatment is provided under written informed consent that explains its investigational status, the available evidence, and the alternatives, with cells sourced from accredited facilities.
What Wharton's Jelly Is
Wharton's jelly is the gelatinous connective tissue found within the umbilical cord, donated after full-term, healthy births and screened according to applicable tissue-sourcing standards. In regenerative medicine it is studied for its potential to support the body's natural repair processes. Research into Wharton's jelly for orthopedic and musculoskeletal use is still developing, and TC Regen discusses what is and is not established with each patient.
How TC Regen Uses It
At TC Regen, Wharton's jelly therapy is delivered by injection under image guidance to the targeted area, selected by the physician based on the structural diagnosis. Because these tissue products are not FDA-approved, the treatment is provided under written informed consent that explains its investigational status, the available evidence, and the alternatives, with cells sourced from accredited facilities.
"We're transparent about what's established and what's still being studied. That honesty is part of how we practice." — TC Regen Clinical Approach
"We're transparent about what's established and what's still being studied. That honesty is part of how we practice." — TC Regen Clinical Approach
"We're transparent about what's established and what's still being studied. That honesty is part of how we practice." — TC Regen Clinical Approach
What Patients Can Expect
A Wharton's jelly visit at TC Regen is typically performed in a single in-office appointment of 30 to 45 minutes. Most patients return to light activity within a few days, with any change developing gradually over several weeks. Because the treatment is not FDA-approved and the evidence is still developing, TC Regen physicians review realistic expectations, risks, and follow-up plans with every patient.
What Patients Can Expect
A Wharton's jelly visit at TC Regen is typically performed in a single in-office appointment of 30 to 45 minutes. Most patients return to light activity within a few days, with any change developing gradually over several weeks. Because the treatment is not FDA-approved and the evidence is still developing, TC Regen physicians review realistic expectations, risks, and follow-up plans with every patient.
Talk to a TC Regen physician
Talk to a TC Regen physician
Every treatment plan starts with an evaluation. Schedule a consultation to find out which options fit your diagnosis.
Every treatment plan starts with an evaluation. Schedule a consultation to find out which options fit your diagnosis.